Ocuphire Pharma, Inc. OCUP
Trading inactive
OCUP
Ocuphire Pharma, Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc. PLX
Protalix BioTherapeutics, Inc. EYPT
EyePoint Pharmaceuticals, Inc. SLS
SELLAS Life Sciences Group, Inc. RVPHW
Reviva Pharmaceuticals Holdings, Inc. EYEN
Eyenovia, Inc. CGTX
Cognition Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. KOD
Kodiak Sciences Inc.
Ocuphire Pharma, Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc. PLX
Protalix BioTherapeutics, Inc. EYPT
EyePoint Pharmaceuticals, Inc. SLS
SELLAS Life Sciences Group, Inc. RVPHW
Reviva Pharmaceuticals Holdings, Inc. EYEN
Eyenovia, Inc. CGTX
Cognition Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. KOD
Kodiak Sciences Inc.
Performance
| Periode | OCUP | RVPH | PLX | EYPT | SLS | RVPHW | EYEN | CGTX | RNAZ | KOD |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -33.90 % | -3.68 % | -2.07 % | 152.23 % | 69.03 % | -24.53 % | 749.47 % | 418.56 % | 25.11 % | 444.50 % |
| YTD | -61.89 % | -67.67 % | 19.80 % | 68.99 % | 78.50 % | -80.74 % | -15.94 % | 153.08 % | -79.54 % | 37.70 % |
| 1Y | -58.36 % | -47.16 % | 122.64 % | 33.43 % | 52.80 % | -45.83 % | -77.91 % | 329.17 % | -96.86 % | 310.73 % |
| 3Y | -65.59 % | -80.60 % | 129.13 % | 145.83 % | 2.69 % | -90.37 % | -95.48 % | 11.59 % | -100.00 % | 70.55 % |
| 5Y | -85.38 % | -93.97 % | -37.23 % | 166.08 % | -27.65 % | -89.39 % | -97.18 % | -85.67 % | -100.00 % | -18.64 % |
| 10Y | -99.65 % | -93.31 % | -78.15 % | -64.29 % | -100.00 % | -85.56 % | -98.98 % | -85.67 % | -100.00 % | 484.73 % |
| From the beginning | -99.92 % | -93.31 % | -99.72 % | -96.62 % | -100.00 % | -85.56 % | -98.98 % | -85.67 % | -100.00 % | 484.73 % |